Detalhe da pesquisa
1.
LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis.
J Bioenerg Biomembr
; 56(2): 181-191, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411863
2.
Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer.
BMC Pulm Med
; 24(1): 159, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561695
3.
Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
Biochem Genet
; 61(4): 1528-1547, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658310
4.
Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin ß family-related genes.
J Clin Lab Anal
; 36(6): e24419, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403268
5.
YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways.
Mol Cell Biochem
; 475(1-2): 137-149, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32813142
6.
Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.
Pharmacol Res
; 155: 104691, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32070721
7.
Noninvasive 3D-CT simulation versus glue injection to localize small pulmonary nodules prior to anatomical segmentectomy: a randomized controlled trial.
Interdiscip Cardiovasc Thorac Surg
; 38(1)2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725345
8.
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021.
Ther Adv Drug Saf
; 15: 20420986231224227, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293566
9.
Local government debt and labor income share: Evidence from China.
PLoS One
; 18(10): e0293494, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883481
10.
Tumor-promoting roles of HMMR in lung adenocarcinoma.
Mutat Res
; 826: 111811, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603370
11.
A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape.
Front Oncol
; 13: 1180723, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37476379
12.
Cost-effectiveness of serplulimab as first-line therapy for extensive-stage small cell lung cancer in China.
Front Immunol
; 14: 1223020, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720211
13.
Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study.
Front Pharmacol
; 14: 1343650, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273821
14.
Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature.
Ther Adv Drug Saf
; 14: 20420986231200746, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37780667
15.
CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC).
Bioengineered
; 13(2): 3651-3664, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230201
16.
Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies.
Front Oncol
; 12: 804212, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223483
17.
Insights into Regulatory Factors in Megakaryocyte Development and Function: Basic Mechanisms and Potential Targets.
Front Biosci (Landmark Ed)
; 27(11): 313, 2022 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472109
18.
The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions.
Front Pharmacol
; 13: 950923, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313336
19.
Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system.
Front Pharmacol
; 13: 989032, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36532784
20.
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma.
Front Genet
; 12: 681277, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34306024